Immunocore (IMCR) News Today $32.34 +0.39 (+1.20%) As of 12:34 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share News and Trends Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Immunocore Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2026 September 2026 August 2026 July 2026 June 2026 May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 Time Period More filters Fewer filters Done Immunocore (NASDAQ:IMCR) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell?October 28 at 3:39 AM | marketbeat.comImmunocore (NASDAQ:IMCR) Earns Buy Rating from HC WainwrightOctober 26 at 1:23 PM | marketbeat.comImmunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Stock Has Average Price Target of $56.38October 22, 2026 | americanbankingnews.comImmunocore (NASDAQ:IMCR) Stock Price Up 8% - Here's What HappenedOctober 20, 2026 | marketbeat.comImmunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Stock Rated "Moderate Buy" by Wall Street BrokeragesOctober 17, 2026 | marketbeat.comImmunocore Doses First Patient in Phase 1 Trial of Type 1 Diabetes TherapyOctober 15, 2026 | finance.yahoo.comImmunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetesOctober 15, 2026 | globenewswire.comImmunocore Holdings stock hits 52-week low at 27.5 USDOctober 14, 2026 | ca.investing.comImmunocore (NASDAQ:IMCR) Sets New 52-Week Low - What's Next?October 14, 2026 | marketbeat.comImmunocore: Advanced Cutaneous Melanoma Data Catalysts Feel CrucialSeptember 29, 2026 | seekingalpha.comImmunocore Holdings plc (IMCR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeptember 14, 2026 | seekingalpha.comImmunocore Completes Enrollment in Study of Potential Advanced Melanoma TreatmentSeptember 14, 2026 | finance.yahoo.comImmunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanomaSeptember 14, 2026 | globenewswire.comImmunocore to present at upcoming investor conferencesSeptember 1, 2026 | globenewswire.comImmunocore outlines TEBE-AM data as early as end of 2026 while scaling KIMMTRAK beyond ~1,000 patients per yearAugust 7, 2026 | seekingalpha.comImmunocore Holdings plc 2026 Q2 - Results - Earnings Call PresentationAugust 7, 2026 | seekingalpha.comImmunocore Holdings PLC (IMCR) (Q2 2026) Earnings Call Highlights: Kimtrak Growth and Pipeline ...August 6, 2026 | finance.yahoo.comImmunocore Holdings plc (IMCR) Q2 2026 Earnings Call TranscriptAugust 6, 2026 | seekingalpha.comImmunocore to report second quarter 2026 financial results and host call on August 6, 2026July 30, 2026 | globenewswire.comIs Immunocore Holdings (IMCR) Undervalued After Its Recent Share Price Rebound?July 9, 2026 | finance.yahoo.comImmunocore: KIMMTRAK Is Becoming A Cash Engine For A Much Larger TCR PlatformJune 24, 2026 | seekingalpha.comIs Immunocore Holdings (IMCR) One of the Best Small Cap Stocks to Buy for the Long Term?June 22, 2026 | finance.yahoo.comImmunocore Holdings (IMCR) Stock Could Be 57% Below Fair Value After Recent WeaknessJune 20, 2026 | finance.yahoo.comImmunocore Holdings (IMCR) Gets a Buy from H.C. WainwrightJune 8, 2026 | theglobeandmail.comAssessing Immunocore Holdings (IMCR) Valuation After New Brenetafusp Data At The 2026 ASCO MeetingJune 1, 2026 | finance.yahoo.comImmunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanomaMay 31, 2026 | globenewswire.comImmunocore Holdings Plc Shs Sponsored American Depositary Shares Repr 1 ShMay 14, 2026 | cnn.comA Look At Immunocore (IMCR) Valuation After Strong Q1 2026 Results And New KIMMTRAK Survival DataMay 8, 2026 | finance.yahoo.comImmunocore (IMCR) Is Up 10.1% After Q1 Profitability Jumps On Higher Revenue And EfficiencyMay 7, 2026 | finance.yahoo.comImmunocore reports first quarter financial results and provides a business updateMay 6, 2026 | globenewswire.comKIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanomaApril 19, 2026 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Immunocore Holdings (IMCR)April 16, 2026 | theglobeandmail.comImmunocore to present at the 25th Annual Needham Virtual Healthcare ConferenceApril 6, 2026 | globenewswire.comA Look At Immunocore (IMCR) Valuation After Jefferies Downgrade And Kimmtrak Growth ConcernsMarch 28, 2026 | finance.yahoo.comJefferies Downgrades Immunocore Holdings plc (IMCR) to Hold with a $33 Price TargetMarch 25, 2026 | insidermonkey.comImmunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meetingMarch 17, 2026 | globenewswire.comJefferies downgrades Immunocore Holdings plc - depositary receipt (IMCR)March 17, 2026 | msn.comImmunocore to present at upcoming investor conferencesMarch 3, 2026 | globenewswire.comIs It Time To Revisit Immunocore Holdings (IMCR) After Recent Pipeline Progress?March 1, 2026 | finance.yahoo.comImmunocore Holdings plc 2025 Q4 - Results - Earnings Call PresentationFebruary 25, 2026 | seekingalpha.comImmunocore Holdings PLC (IMCR) Q4 2025 Earnings Call Highlights: Robust Revenue Growth and ...February 25, 2026 | finance.yahoo.comImmunocore Holdings PLC (IMCR) Q4 2025 Earnings Call Highlights: Robust Revenue Growth and ...February 25, 2026 | finance.yahoo.comImmunocore Holdings plc (IMCR) Q4 2025 Earnings Call TranscriptFebruary 25, 2026 | seekingalpha.comImmunocore reports fourth quarter and full year 2025 financial results and provides a business updateFebruary 25, 2026 | globenewswire.comWhy The Narrative Around Immunocore (IMCR) Is Shifting With New Analyst Targets And 2026 HopesFebruary 25, 2026 | finance.yahoo.com6IMCR : Insights into Immunocore Hldgs's Upcoming...February 24, 2026 | benzinga.comImmunocore (NASDAQ:IMCR) CAO Sells 698 SharesFebruary 20, 2026 | insidertrades.comImmunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025February 18, 2026 | globenewswire.comIs Immunocore (IMCR) Offering Opportunity After Years Of Share Price WeaknessFebruary 2, 2026 | finance.yahoo.comImmunocore Holdings (IMCR) is One of the Best Small Cap Stocks Ready to Explode in 2026January 31, 2026 | finance.yahoo.com Immunocore Media Mentions By Week Immunocore Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMCR News Sentiment▼0.480.69▲Average Healthcare News Sentiment Immunocore News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMCR Articles This Week▼53▲IMCR Articles Average Week Immunocore Trends on MarketBeatThis week vs. last weekNew Followers1Searches2+100%Page Views1,653-13% Get Immunocore News Delivered to You Automatically Sign up to receive the latest news and ratings for IMCR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies KNSA News Today LGND News Today RYTM News Today KOD News Today IMVT News Today GRAL News Today MIRM News Today CGON News Today COGT News Today PTCT News Today News and Trends Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Immunocore dated 10/28/2026. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredElon Musk about to bankrupt Amazon, Microsoft & Google?Jeff Brown, the former tech executive who called the rise of Bitcoin, Tesla, and Nvidia years early, is tracki...Brownstone Research | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredThe chip inside every TeslaEvery Tesla built since 2012 pays this small, overlooked supplier a fee for its technology. So does every Star...Behind the Markets | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunocore Holdings PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunocore With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
